Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background: Giant pituitary neuroendocrine tumors (GPitNETs) are challenging tumors with low rates of gross total resection (GTR) and high morbidity. Previously reported machine learning (ML) models for prediction of pituitary neuroendocrine tumor extent of resection (EOR) using preoperative imaging included a heterogenous dataset of functional and nonfunctional pituitary neuroendocrine tumors of various sizes leading to variability in results.

Methods: A retrospective study of 100 large nonfunctioning GPitNETs (≥3 cm diameter, >10 cm³ volume) was conducted to develop predictive models for GTR or EOR based on 5 variables: tumor diameter, shape, revised Knosp grade, and modified Hardy classifications for sellar and extrasellar invasion. Model performance was assessed using receiver operating characteristic-area under the curve (AUC) and confusion matrix metrics.

Results: The median preoperative tumor volume was 17.35 cm (interquartile range: 12.4-27.0). The median EOR was 97.6% (interquartile range: 84.9-100), and GTR was achieved in 49% of patients. The most predictive variables were the modified Hardy classification for extrasellar extension and Knosp grade (AUC of 0.771 and 0.713, respectively). Among the constructed ML models, the extreme gradient boost algorithm had the highest predictive capability, with an internal validation AUC of 0.86, while the external validation sensitivity, specificity, positive, and negative predictive values were 84%, 77%, 78%, and 82%, respectively.

Conclusions: Utilizing preoperative imaging parameters in a 3-dimensional manner proves highly valuable in predicting the EOR for nonfunctioning GPitNETs. These predictions can be easily calculated using an online open-access application: http://emoryskullbase.shinyapps.io/giant_pituitary_adenoma_resection/.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.wneu.2024.123653DOI Listing

Publication Analysis

Top Keywords

pituitary neuroendocrine
16
giant pituitary
8
neuroendocrine tumor
8
neuroendocrine tumors
8
preoperative imaging
8
nonfunctioning gpitnets
8
knosp grade
8
modified hardy
8
interquartile range
8
predictive
5

Similar Publications

Objective: Characterize disease-specific mortality rates in patients with acromegaly on pegvisomant and identify pertinent risk factors, including on-therapy insulin-like growth factor I (IGF-I) levels.

Design: Retrospective cohort analysis of ACROSTUDY, a global surveillance study of patients with acromegaly receiving pegvisomant.

Methods: Cumulative incidence function to estimate disease-specific mortality and regression analyses to characterize risk factors.

View Article and Find Full Text PDF

Insulin tolerance tests (ITTs), glucagon tests, and low or standard-dose adrenocorticotropic hormone tests are used to evaluate the hypothalamic-pituitary-adrenal (HPA) axis. While ITT is considered the gold standard test for stimulating both the cortisol and growth hormone axis, its use in young children carries a risk of hypoglycemia, making it potentially unsafe. Recent studies indicate that L-dopa stimulates the release of adrenocorticotropic hormone and cortisol.

View Article and Find Full Text PDF

Background: Ectopic ACTH syndrome (EAS) is caused by non-pituitary neuroendocrine tumor (NET) which produces adrenocorticotropic hormone (ACTH).

Objective: To identify survival predictors and to analyze long-term outcomes in patients with EAS.

Methods: Medical records of patients with verified EAS between 1990 and 2024 were analyzed to obtain the initial clinical and biochemical data along with subsequent interventions and survival outcomes.

View Article and Find Full Text PDF

Objectives: To clarify the role of hippocampal glutamate system in regulating HPA axis in mediating the effect of electroacupuncture (EA) at the heart meridian for improving myocardial injury in rats with acute myocardial ischemia (AMI).

Methods: Male SD rats were randomized into sham-operated group, AMI group, EA group, and L-glutamic acid+EA group (=9). Rat models of AMI were established by left descending coronary artery ligation, and EA was applied at the "Shenmen-Tongli" segment; the rats in L-glutamic acid+EA group were subjected to microinjection of L-glutamic acid into the bilateral hippocampus prior to AMI modeling and EA treatment.

View Article and Find Full Text PDF

Introduction: Pituitary adenomas (PAs) are generally benign neoplasms, though in rare cases may exhibit aggressive behavior. In 2024, the PANOMEN-3 workshop released a new clinical-pathological classification. The objective of this study was to examine the potential of the PANOMEN-3 classification to predict prognosis of PAs and guide treatment in our single center cohort of patients with PAs.

View Article and Find Full Text PDF